Jim Barry
QuietNamed in filings at Bridge Street
- Board seats filed
- 11
all filings on record
Named in filings at Bridge Street
all filings on record
last 24 months
from a verified or cited source
| AgNovos Bioscience | Not yet classified | May 2023 | None on file |
| BioSig Technologies | Medical devices | November 2022 | None on file |
| Cardiac Implants | Not yet classified | August 2022 | None on file |
| Offaly Good Foods | Not yet classified | June 2020 | None on file |
| PharmaCann | Not yet classified | May 2020 | None on file |
| Grid7 | Climate & energy | May 2018 | KSN, Mustard Seed, Seedbrite Venture Partners, Techstars Ventures |
| EyePoint Pharmaceuticals | Not yet classified | March 2018 | None on file |
| Appian Two | Not yet classified | September 2017 | None on file |
| NEOPHARM PHARMACANN INVESTORS II | Not yet classified | February 2017 | None on file |
| InspireMD | Not yet classified | March 2016 | None on file |
| PEAK MANAGEMENT GROUP | Not yet classified | November 2014 | None on file |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The sector is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Too few filings to infer a focus. 2 of 11 filed seats classified so far.